Domain > ir.opusgtx.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2024-10-18	184.73.186.24 (ClassC)
2025-05-04	54.183.230.231 (ClassC)
2025-05-08	13.57.74.156 (ClassC)
2025-05-20	13.56.2.69 (ClassC)
2025-07-04	34.236.86.94 (ClassC)
2025-07-14	52.9.67.7 (ClassC)
2025-07-18	13.56.202.220 (ClassC)
2025-08-23	13.56.170.192 (ClassC)
2025-09-08	52.8.247.126 (ClassC)
2025-09-18	35.171.180.101 (ClassC)
2026-01-30	52.8.242.167 (ClassC)
2026-02-13	52.52.175.53 (ClassC)

HTTP/1.1 200 OKDate: Sun, 04 May 2025 06:54:56 GMTServer: ApacheStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffPermissions-Policy: microphone()

!DOCTYPE html>html langen>    head>        meta http-equivx-ua-compatible contentieedge>        meta charsetutf-8>                        link relalternate typeapplication/rss+xml titleOpus Genetics, Inc. - Recent News hrefhttps://ir.opusgtx.com/press-releases/rss />                        title>Opus Genetics, Inc. (IRD)/title>                link relcanonical hrefhttps://ir.opusgtx.com>meta propertyog:url contenthttps://ir.opusgtx.com>meta propertyog:site_name contentOpus Genetics, Inc.>meta propertyog:title contentInvestors>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_34a9089792551e4670df9016c0509fad/ocuphire/db/466/4307/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>meta propertyog:description contentThe company is a clinical-stage ophthalmic biotechnology &nbsp;company developing therapies to treat patients with inherited retinal diseases (IRDs) and&nbsp; other ophthalmic disorders. The pipeline includes adeno-associated virus (AAV)-based…>meta namedescription contentThe company is a clinical-stage ophthalmic biotechnology &nbsp;company developing therapies to treat patients with inherited retinal diseases (IRDs) and&nbsp; other ophthalmic disorders. The pipeline includes adeno-associated virus (AAV)-based…>script typeapplication/ld+json>	{@context:http://schema.org,@type:Corporation,name:Opus Genetics, Inc.,address:{@type:PostalAddress,streetAddress:8 Davis Drive ,addressLocality:Durham, NC,postalCode:27709,addressCountry:},legalName:Opus Genetics, Inc.,description:The company is a clinical-stage ophthalmic biotechnology  company developing therapies to treat patients with inherited retinal diseases (IRDs) and  other ophthalmic disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The companyu2019s most advanced gene therapy progr

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > ir.opusgtx.com

Is this malicious?

DNS Resolutions

Port 443